Maryam is the founder of OncoFlow, an AI-powered cancer intelligence platform transforming unstructured clinical data into actionable insights for cancer multidisciplinary teams. OncoFlow is currently being tested, piloted and deployed across Europe and Asia to streamline decision-making in breast cancer and beyond. The company was one of only four selected for the Medicines and Healthcare products Regulatory Agency’s (MHRA’s) pioneering AI Airlock programme, where it worked with UK regulators to define safe and effective deployment pathways for medical AI tools. Maryam brings a unique perspective at the intersection of clinical workflows, AI infrastructure, and regulatory innovation.